Journal of Cystic Fibrosis

Scope & Guideline

Fostering impactful insights for better patient outcomes.

Introduction

Explore the comprehensive scope of Journal of Cystic Fibrosis through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Journal of Cystic Fibrosis in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1569-1993
PublisherELSEVIER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 2002 to 2024
AbbreviationJ CYST FIBROS / J. Cyst. Fibros
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Journal of Cystic Fibrosis aims to advance the understanding and treatment of cystic fibrosis (CF) through comprehensive research. It encompasses a wide range of topics related to the disease, focusing on innovative therapies, clinical management, and the associated health outcomes.
  1. CFTR Modulator Therapy:
    A significant focus on the effectiveness and safety of CFTR modulators, including elexacaftor, tezacaftor, and ivacaftor, in treating various CF genotypes.
  2. Microbiome Research:
    Exploration of the cystic fibrosis microbiome, including its interactions with disease pathology and treatment responses, particularly regarding Pseudomonas aeruginosa and other pathogens.
  3. Quality of Life and Patient-Centered Care:
    Assessment of health-related quality of life and the psychosocial impact of cystic fibrosis on patients and their families, emphasizing the importance of holistic care.
  4. Nutritional Management:
    Research on dietary interventions, nutritional status, and gastrointestinal complications in cystic fibrosis, recognizing the critical role of nutrition in disease management.
  5. Longitudinal Studies and Registries:
    Utilization of registry data and longitudinal studies to understand disease progression, treatment outcomes, and long-term health implications for cystic fibrosis patients.
  6. Clinical Guidelines and Standards of Care:
    Development and dissemination of evidence-based clinical guidelines to improve standard care practices for cystic fibrosis patients across different demographics.
The Journal of Cystic Fibrosis is witnessing a surge in research themes that reflect the evolving landscape of cystic fibrosis treatment and care. These emerging scopes highlight the journal's responsiveness to new challenges and innovations within the field.
  1. Telehealth and Digital Health Innovations:
    An increasing number of studies are focusing on telehealth implementations and digital health tools to improve care delivery and patient engagement, especially in light of the COVID-19 pandemic.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomic approaches is gaining traction, aiming to tailor CF treatments based on individual genetic profiles, thereby enhancing therapeutic efficacy.
  3. Impact of Socioeconomic Factors:
    Emerging themes are addressing the influence of socioeconomic factors on health outcomes in cystic fibrosis, emphasizing the need for equitable access to care and treatment.
  4. Mental Health and Psychosocial Research:
    There is a growing emphasis on mental health outcomes and the psychosocial impact of living with cystic fibrosis, highlighting the importance of addressing emotional well-being in treatment plans.
  5. Longitudinal Outcomes of Novel Therapies:
    Studies focusing on the long-term effectiveness and safety of recently approved therapies, particularly CFTR modulators, are becoming increasingly prevalent.

Declining or Waning

While the Journal of Cystic Fibrosis continues to thrive with emerging topics, some areas of research have seen a decline in focus over recent years. These waning themes may reflect shifts in clinical priorities or advancements in treatment modalities.
  1. Basic Science Research:
    There has been a noticeable decrease in basic science studies focused solely on the pathology of cystic fibrosis, as the field shifts towards applied research and clinical trials.
  2. Traditional Antibiotic Therapies:
    Interest in conventional antibiotic therapies appears to be waning, likely due to the rise of new CFTR modulators and alternative treatment strategies that target the underlying cause of the disease.
  3. Palliative Care Research:
    Although still important, there seems to be less emphasis on palliative care studies compared to previous years, possibly overshadowed by advancements in curative and disease-modifying therapies.
  4. Longitudinal Studies of Older Treatment Regimens:
    Research focusing on the long-term efficacy of older treatment regimens, such as dornase alfa, is becoming less frequent as newer therapies dominate clinical discussions.

Similar Journals

Journal of Allergy and Clinical Immunology-In Practice

Bridging research and practice for better patient outcomes.
Publisher: ELSEVIERISSN: 2213-2198Frequency: 6 issues/year

The Journal of Allergy and Clinical Immunology-In Practice, published by ELSEVIER, stands as a leading platform in the field of allergy and immunology, specifically tailored for practitioners and researchers. With an impressive 2023 Q1 ranking in both the Immunology and Allergy categories, this journal demonstrates a significant impact within the academic community, evidenced by its Scopus rank #41 out of 233 and an impressive percentile rank of 82. The journal focuses on providing advanced studies, clinical findings, and innovative treatment methodologies that address current challenges in allergy and immunology, making it a vital resource for professionals in these fields. With a comprehensive coverage of relevant topics from 2013 to 2024, the journal continues to evolve alongside emerging trends and developments in clinical practice, fostering an environment conducive to scholarly research and application. Although it currently does not offer open access, authors and readers can access a wealth of information and contribute to ongoing dialogues through its robust publication platform.

Journal of the National Comprehensive Cancer Network

Advancing Oncology: Pioneering Research for Better Patient Outcomes
Publisher: HARBORSIDE PRESSISSN: 1540-1405Frequency: 15 issues/year

The Journal of the National Comprehensive Cancer Network (ISSN: 1540-1405, E-ISSN: 1540-1413) is a premier publication in the field of oncology, established by HARBORSIDE PRESS and running since 2003. This highly respected journal holds a remarkable Q1 ranking in both Medicine (Miscellaneous) and Oncology categories, showcasing its significant influence and contribution to cancer research, with a Scopus ranking placing it within the top 5% of its field (Rank #20 out of 404). Aimed at a diverse audience including researchers, clinicians, and students, the journal publishes a wide range of articles that explore cutting-edge findings, clinical practices, and evidence-based guidelines in cancer care. With its commitment to advancing the understanding and treatment of cancer, it serves as a vital resource for professionals dedicated to improving patient outcomes. Although it does not currently offer open access, its impactful content continues to be a cornerstone for anyone involved in oncology research and practice.

Practical Radiation Oncology

Advancing the Frontiers of Radiation Oncology
Publisher: ELSEVIER SCIENCE INCISSN: 1879-8500Frequency: 6 issues/year

Practical Radiation Oncology is a premier journal published by Elsevier Science Inc., focusing on the critically important fields of Oncology and Radiology, Nuclear Medicine, and Imaging. With an ISSN of 1879-8500, this journal serves as an essential resource for professionals and researchers dedicated to advancing the practice and research of radiation oncology. Established in 2011 and continuing through 2024, it has quickly gained recognition, achieving a prestigious Q2 ranking in Oncology and an exceptional Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. The journal, housed in New York, USA, provides a platform for innovative research and practical insights, aimed at enhancing therapeutic practices and improving patient outcomes. As part of its commitment to fostering scientific dialogue, it also features a range of articles, reviews, and clinical studies that cater to the diverse interests of its readers. Hard-copy availability combined with digital access ensures a broad reach for the latest advancements in the field.

EUROPEAN RESPIRATORY JOURNAL

Elevating Knowledge in Pulmonary Medicine
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: 0903-1936Frequency: 12 issues/year

The EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.

Gut and Liver

Elevating standards in Gastroenterology and Hepatology.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.

Journal of Diabetes Investigation

Empowering discoveries in endocrinology and metabolism.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Pain Physician

Elevating standards in anesthesiology and pain medicine.
Publisher: AM SOC INTERVENTIONAL PAIN PHYSICIANSISSN: 1533-3159Frequency: 6 issues/year

Pain Physician is a premier journal that plays a critical role in the field of anesthesiology and pain medicine, published by the American Society of Interventional Pain Physicians. With an impressive impact factor and ranked in the Q1 category of Scopus for its significant contributions to the literature, the journal has established itself as a leading source of innovative research and clinical insights since its inception in 1999. Covering a wide array of topics related to pain management, the journal aims to disseminate high-quality studies that inform best practices and enhance patient care. As a well-respected publication, Pain Physician offers essential access to the latest developments and methodologies in pain therapy to researchers, clinicians, and students alike, fostering a deeper understanding of this critical area of medicine. With its commitment to advancing research and practice, Pain Physician is an invaluable resource for those dedicated to improving the quality of life for individuals suffering from chronic pain.

Pain Management

Elevating Standards in Anesthesiology and Pain Medicine.
Publisher: FUTURE MEDICINE LTDISSN: 1758-1869Frequency: 12 issues/year

Pain Management, published by Future Medicine Ltd, is a premier journal that serves the fields of anesthesiology, pain medicine, and dentistry. With its ISSN 1758-1869 and E-ISSN 1758-1877, this journal is committed to advancing knowledge and practice through high-quality research articles, clinical studies, and expert reviews. The journal has established itself as a pivotal resource in pain management with a commendable impact factor and recognition in category quartiles, achieving Q2 rankings in Anesthesiology and Pain Medicine, as well as in miscellaneous Medicine and Dentistry categories as of 2023. Researchers and professionals will find a wealth of information in its comprehensive articles, which are essential for staying at the forefront of developments in pain management therapies and techniques. Although access is not open, the journal is recognized for its rigor and significance in shaping the future of pain management practices globally. Join the community of experts engaging in cutting-edge discussions by exploring the impactful research being published in this essential resource.

Therapeutic Advances in Gastroenterology

Elevating standards in gastroenterology research.
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-283XFrequency: 1 issue/year

Therapeutic Advances in Gastroenterology, published by SAGE Publications Ltd, is a premier open access journal dedicated to the advancement of knowledge in the field of gastroenterology. Since its inception in 2008 and its transition to open access in 2018, the journal has consistently provided high-quality peer-reviewed research articles, review papers, and clinical studies that address the latest therapeutic advancements and challenges in gastrointestinal medicine. With an impressive impact factor and a 2023 Scopus ranking placing it in the Q1 quartile of gastroenterology journals, it stands as a leading platform for researchers, clinicians, and healthcare professionals. The journal’s commitment to disseminating impactful research has positioned it at the forefront of academic discourse, offering a vital resource for those devoted to improving patient outcomes in digestive health. The United Kingdom-based journal invites submissions that contribute to the understanding and treatment of gastrointestinal disorders, ensuring that cutting-edge findings reach a global audience.

SEMINARS IN DIALYSIS

Pioneering research and insights in kidney health.
Publisher: WILEYISSN: 0894-0959Frequency: 6 issues/year

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.